NSF Funds

The recent article “NSF Reinstitutes Training Grants To Spur Interdisciplinary Science” (The Scientist, Oct. 2, 1989, page 1) leads me to wonder if NSF has fully considered the availability of jobs and research funding for the trainees once they get their degrees. It appears that many of these students will be trained in fields in which research is done primarily at universities. To make adequate use of their training they will need startup funds and ongoing grant support in amount

Written byPaul Hambourger
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The recent article “NSF Reinstitutes Training Grants To Spur Interdisciplinary Science” (The Scientist, Oct. 2, 1989, page 1) leads me to wonder if NSF has fully considered the availability of jobs and research funding for the trainees once they get their degrees. It appears that many of these students will be trained in fields in which research is done primarily at universities. To make adequate use of their training they will need startup funds and ongoing grant support in amounts far. exceeding the original traineeship costs (and will themselves turn out additional new Ph.D.’s). I doubt if sufficient moneys will be available in an era of long-term federal and university budget shortfalls.

We must not forget the lesson of the 1 960s, when fear of a shortage of scientists led to the training of many talented people for jobs and grants that failed to materialize. Perhaps NSF should concentrate its ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies